WEEKLY NEWS - DECEMBER 08, 2008
This article is part of MIP Week, a weekly email newsletter written by the editors of Managing IP magazine. Take a one week trial to Managing IP and find many more related articles.
Indian court sets aside Roche’s patent
Peter Ollier, Hong Kong
The Madras High Court last week set aside a patent granted to Swiss pharmaceutical company F Hoffman La Roche for its blockbuster anti-infection medicine valganciclovir because a pre-grant opposition by two NGOs was not heard
The decision is another blow to Roche after the company failed to get a preliminary injunction in March against Indian generic drug maker Cipla, which is making its own version of Tarceva, Roche’s lung cancer medication. That case is currently under appeal.
The Madras High Court sent the valganciclovir matter back to the patent controller on December 2 and has ordered that the pre-grant opposition be heard by the end of January 2009.
Continue reading this article by clicking here (subscription or free trial required)
